The latest price target for Cryo-Cell International (AMEX:CCEL) was reported by Maxim Group on August 29, 2022. The analyst firm set a price target for $12.00 expecting CCEL to rise to within 12 months (a possible 37.46% upside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Cryo-Cell International (AMEX:CCEL) was provided by Maxim Group, and Cryo-Cell International initiated their buy rating.

There is no last upgrade for Cryo-Cell International

There is no last downgrade for Cryo-Cell International.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cryo-Cell International, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cryo-Cell International was filed on August 29, 2022 so you should expect the next rating to be made available sometime around August 29, 2023.

While ratings are subjective and will change, the latest Cryo-Cell International (CCEL) rating was a initiated with a price target of $0.00 to $12.00. The current price Cryo-Cell International (CCEL) is trading at is $8.73, which is within the analyst’s predicted range.